EyeCon 2026 Banner
|Articles|January 15, 2005

New viscous-dispersive viscoelastic found promising

Poughkeepsie, NY—DisCoVisc, a new viscous-dispersive ophthalmic viscosurgical device (OVD) from Alcon Laboratories, performed comparably to Healon in a randomized, FDA phase III clinical trial in key measurements such as endothelial cell density and IOP control, according to Satish Modi, MD.


Latest CME